...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Reports of Exempt Distribution
1
Feb 04, 2023 09:01AM

Its absolutely amazing how both companies,,the sister one included can not capitalize on anything positive around them or invloved with them,,,,,..good news or sector interest all seems to be a hindrance and a mute influence on our value,,!!

We could have the formula to cure all cancers and the team would fail to get the news out where it would add sharevalue,,,,,its enuff to stop all investment in Canadian Biotech!!! Not only with these two. And all the while the science and story inproves.

Its a head scratcher!!!!

 

 

2
Feb 22, 2023 09:43AM
1
Feb 24, 2023 10:39AM
Share
New Message
Please login to post a reply